SEER
Seer, Inc.
$1.87
-0.53%
2026-05-08
About Seer, Inc.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Key Fundamentals
Forward P/E
-1.73
EPS (TTM)
$-1.28
ROE
-25.1%
Revenue Growth (YoY)
5.0%
Profit Margin
0.0%
Debt/Equity
9.12
Price/Book
0.41
Beta
1.64
Market Cap
$103.2M
Avg Volume (10D)
540K
Recent Breakout Signals
No recent breakout signals detected for SEER.
Recent Price Range (60 Days)
60D High
$2.11
60D Low
$1.65
Avg Volume
385K
Latest Close
$1.87
Get breakout alerts for SEER
Sign up for Breakout Scanner to receive daily notifications when SEER triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Seer, Inc. (SEER) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SEER daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SEER operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.